Blood‐based genes and co‐expression network levels are associated with AD/MCI diagnosis, cognitive, and neuroimaging phenotypes and preserved in the brain

Abstract

Background: Most existing biomarkers for Alzheimer’s disease (AD) inform on core AD pathologies in the central nervous system, namely amyloid, tau and neurodegeneration (ATN).

The paper